Study guide

2.3 Laboratory & Diagnostic Evaluation in Geriatrics

Board Certified Specialist in Gerontological Nutrition CSG

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Geriatric Nutrition Screening & Anthropometrics

1.1 Validated Geriatric Screening Tools 1.2 Anthropometrics, Height Estimation & Weight History 1.3 Sarcopenia & Functional Assessment 1.4 Frailty Phenotypes & Functional Independence

2 Chapter 2: Clinical Assessment & Physical Examination

2.1 Nutrition-Focused Physical Exam in Older Adults 2.2 Pressure Injury Staging & Etiology 2.3 Laboratory & Diagnostic Evaluation in Geriatrics

3 Chapter 3: Health History, Multimorbidity & Pharmacotherapy

3.1 Dietary Intake & Lifestyle History in Older Adults 3.2 Multimorbidity & Chronic Disease Interactions 3.3 Geriatric Pharmacotherapy & Drug-Nutrient Interactions

4 Chapter 4: Cultural, Psychosocial & Cognitive Considerations

4.1 Socioeconomic Status, SDOH & Food Insecurity 4.2 Living Environments & Social Support Across the Continuum 4.3 Patient-Centered, Cultural & Religious Dietary Practices 4.4 Psychological, Cognitive & Behavioral Factors in Nutrition

5 Chapter 5: Therapeutic Diets, Fortification & Texture Modifications

5.1 Diet Liberalization & Therapeutic Modifications in LTC 5.2 Texture Modifications & The IDDSI Framework 5.3 Nutrient Density & Calorie/Protein Fortification Strategies

6 Chapter 6: Oral Supplements & Nutrition Support

6.1 Oral Nutrition Supplements & Micronutrient Therapy 6.2 Dining Environment, Adaptive Equipment & Mealtime Interventions 6.3 Enteral & Parenteral Nutrition Support in Older Adults

7 Chapter 7: Educational Strategies, Counseling & Caregiver Support

7.1 Behavioral Change & Motivational Interviewing in Geriatrics 7.2 Educational Design & Sensory Impairment Accommodations 7.3 Overcoming Cognitive & Physical Barriers to Nutrition 7.4 Caregiver Engagement, Training & Support Systems

8 Chapter 8: Care Coordination, Palliative Care & Community Programs

8.1 Person-Centered Nutrition Care Planning & Documentation 8.2 Palliative & End-of-Life Nutrition Care 8.3 Interdisciplinary Care Coordination & Transitions of Care 8.4 Federal, State & Community Nutrition Programs

9 Chapter 9: Food Safety & Foodborne Illness in Geriatrics

9.1 Food Handling, Temperature Control & The FDA Food Code 9.2 Highly Susceptible Populations & Geriatric Foodborne Pathogens 9.3 Dietary Staff Training, Sanitation & Kitchen Safety

10 Chapter 10: Foodservice Operations, Emergency Preparedness & LTC Regulations

10.1 Menu Planning & Nutritional Adequacy in Senior Living 10.2 Dining Operations, Service Models & Staffing Resources 10.3 Supply Chain Management & Emergency Preparedness 10.4 CMS Long-Term Care Regulations, F-Tags & QAPI

2.3 Laboratory & Diagnostic Evaluation in Geriatrics

Key Takeaways Explain This Topic AI

Directly measured serum/plasma osmolality above 300 mOsm/kg is the ESPEN action threshold for low-intake dehydration.

BUN:creatinine ratio, urine measures, dry mouth, and skin turgor are not reliable stand-alone low-intake dehydration tests in older adults.

Albumin and prealbumin reflect inflammation and other disease processes and are not measures of protein intake or nutritional adequacy.

MMA supports evaluation of borderline B12 status but can be elevated by renal impairment.

ADA 2026 advises avoiding reliance on HbA1c in very complex/poor health; prioritize avoiding hypoglycemia and symptomatic hyperglycemia.

Last updated: October 2026

2.3 Laboratory & Diagnostic Evaluation in Geriatrics

Interpreting laboratory parameters in older adults requires understanding altered homeostatic reserves, organ senescence, multimorbidity, and polypharmacy. This section reviews four fundamental diagnostic domains in gerontological nutrition: hydration status, the physiological reality of visceral protein markers, differential evaluation of geriatric anemias, and individualized glycemic targets.

1. Hydration Assessment in Older Adults

Dehydration is among the most frequent causes of preventable hospitalizations, delirium, acute kidney injury, and morbidity in the geriatric population.

Physiological Susceptibility to Dehydration

Hypodipsia (Blunted Thirst): Age-related deterioration of osmoreceptor sensitivity in the anterior hypothalamus markedly blunts the physiological thirst sensation. Older adults do not experience thirst until significant hypertonic volume contraction has already occurred.

Renal Concentrating Deficit: Glomerular filtration rate (GFR) and medullary tubular responsiveness to antidiuretic hormone (arginine vasopressin) decline with age, diminishing the kidneys' capacity to concentrate urine and conserve free water.

Reduced Total Body Water (TBW): TBW declines from ∼ 60 % \sim 60\% ∼ 60% in young adults to 45 – 50 % 45\text{--}50\% 45 – 50% in older adults due to age-related loss of muscle mass (sarcopenia) and proportional increases in adipose tissue (which contains minimal water). As a result, even minor fluid deficits produce rapid hyperosmolality.

Voluntary Fluid Restriction: Older adults frequently restrict fluid intake voluntarily to manage urinary incontinence, nocturia, or functional mobility limitations preventing timely access to the toilet.

Clinical Assessment and Low-Intake Dehydration

Dry mouth, altered skin turgor, dark urine, or an elevated BUN:creatinine ratio cannot reliably diagnose low-intake dehydration in older adults. They can prompt assessment but are affected by medications, renal function, sarcopenia, and other conditions. Examine vital signs, losses, intake, mental status, and illness; distinguish low-intake water deficit from extracellular volume depletion due to bleeding, vomiting, diarrhea, or diuresis.

ESPEN recommends directly measured serum/plasma osmolality above 300 mOsm/kg as the action threshold for low-intake dehydration. Interpret glucose and urea because marked elevations can increase osmolality for other reasons. A normal sodium concentration does not exclude low-intake dehydration, and extracellular volume loss may occur with normal or low osmolality.

When direct measurement is unavailable, ESPEN recommends this screening equation, with all input concentrations in mmol/L: Calculated osmolarity = 1.86 ( Na + K ) + 1.15 ( glucose ) + urea + 14 \text{Calculated osmolarity}=1.86(\text{Na}+\text{K})+1.15(\text{glucose})+\text{urea}+14 Calculated osmolarity = 1.86 ( Na + K ) + 1.15 ( glucose ) + urea + 14

A calculated value above 295 mmol/L prompts further assessment and hydration support; it is not the same measurement as osmolality. For Na 140, K 4, glucose 5, and urea 7 mmol/L, the estimate is 294.59 mmol/L. Do not enter BUN in mg/dL into a formula requiring urea in mmol/L.

If the patient is well and can drink safely, support preferred drinks and reassess. If unwell, unable to drink, or showing shock, urgent medical assessment determines oral, subcutaneous, or IV fluid treatment. Do not force a fixed fluid volume in heart or kidney failure.

2. Serum Albumin and Prealbumin in Geriatrics: The Modern Paradigm

For decades, serum albumin ( t 1 / 2 ≈ 20 days t_{1/2} \approx 20\text{ days} t 1/2 ​ ≈ 20 days ) and prealbumin (transthyretin, t 1 / 2 ≈ 2 days t_{1/2} \approx 2\text{ days} t 1/2 ​ ≈ 2 days ) were treated as direct markers of visceral protein stores and nutritional adequacy. Contemporary clinical consensus from the Academy of Nutrition and Dietetics and ASPEN has fundamentally overturned this dogma:

The Clinical Paradigm: Serum albumin and prealbumin are negative acute-phase reactants driven by systemic inflammation , NOT valid indicators of nutritional status, protein stores, or adequacy of dietary intake.

Key Mechanisms:

Hepatic Reprioritization: Proinflammatory cytokines ( interleukin-1 [IL-1] , interleukin-6 [IL-6] , and tumor necrosis factor-alpha [TNF-alpha] ) signal hepatocytes to downregulate the transcription of albumin and prealbumin mRNA. The liver shifts amino acid resources toward synthesizing positive acute-phase proteins (C-reactive protein, ferritin, fibrinogen, complement).

Capillary Leakage: Cytokines disrupt vascular endothelial tight junctions, causing rapid transcapillary extravasation of albumin into the interstitial space.

Clinical Implication: Hypoalbuminemia and low prealbumin reflect the severity of systemic inflammatory response and are strong prognostic biomarkers for mortality, hospital readmission, and surgical complications. However, they cannot be corrected by force-feeding calories or protein while active inflammation persists. Values also depend on fluid distribution, liver synthesis, and renal or gastrointestinal losses; nutritional improvement must be measured using intake, body composition, function, and clinical response.

3. Differential Diagnosis of Geriatric Anemias

Anemia affects over 10% of community-dwelling older adults and up to 50% of nursing home residents. Common adult clinical thresholds for anemia are Hemoglobin < 13.0 g/dL <13.0\text{ g/dL} < 13.0 g/dL in men and < 12.0 g/dL <12.0\text{ g/dL} < 12.0 g/dL in women.

Diagnostic Parameter Anemia of Chronic Disease (ACD) Iron Deficiency Anemia (IDA) Vitamin B12 Deficiency Folate Deficiency

Mean Corpuscular Volume (MCV) Normocytic ( 80 – 100 fL 80\text{--}100\text{ fL} 80 – 100 fL ) or mildly microcytic Microcytic ( < 80 fL <80\text{ fL} < 80 fL ); hypochromic Macrocytic ( > 100 fL >100\text{ fL} > 100 fL ); megaloblastic Macrocytic ( > 100 fL >100\text{ fL} > 100 fL ); megaloblastic

Serum Ferritin Normal or Elevated ( > 100 ng/mL >100\text{ ng/mL} > 100 ng/mL ) Low ( < 30 – 50 ng/mL <30\text{--}50\text{ ng/mL} < 30 – 50 ng/mL ) Normal or elevated Normal

Serum Iron Low Low Normal Normal

Total Iron-Binding Capacity (TIBC) Low or Normal Elevated ( > 400 mcg/dL >400\text{ mcg/dL} > 400 mcg/dL ) Normal Normal

Transferrin Saturation Normal or low ( 10 – 20 % 10\text{--}20\% 10 – 20% ) Severely Low ( < 16 % <16\% < 16% ) Normal Normal

  • Serum Methylmalonic Acid (MMA) Normal Normal Markedly Elevated Normal
  • Serum Homocysteine Normal Normal Elevated Elevated

Primary Etiology in Elderly Hepcidin-mediated iron entrapment in macrophages driven by IL-6 Occult gastrointestinal bleeding (NSAIDs, ulcers, polyps, malignancy) Atrophic gastritis, chronic PPI use, metformin, pernicious anemia Alcoholism, poor dietary intake of leafy greens, methotrexate

Distinguishing Macrocytic Anemias: MMA and Homocysteine

Vitamin B12 functions as an essential coenzyme in two enzymatic pathways:

Conversion of methylmalonyl-CoA to succinyl-CoA (requires B12; independent of folate).

Remethylation of homocysteine to methionine (requires both B12 and folate).

Therefore:

In Vitamin B12 deficiency , both Methylmalonic Acid (MMA) and Homocysteine are elevated.

In Folate deficiency , Homocysteine is elevated, but MMA is not elevated by folate deficiency itself .

Neurological Alert: Untreated Vitamin B12 deficiency can cause irreversible neurological damage (subacute combined degeneration of the spinal cord, paresthesias, sensory ataxia, cognitive deficits). These manifestations can occur without macrocytic anemia. Renal impairment can raise MMA and homocysteine, and homocysteine has multiple determinants; interpret results with renal function and the full clinical assessment. Administering folate to a B12-deficient patient resolves the anemia but allows permanent neurological damage to progress.

4. Individualized Glycemic Targets in Older Adults

The American Diabetes Association (ADA) emphasizes individualized glycemic goals based on functional status, comorbidity burden, and life expectancy to avoid hypoglycemia:

Patient Category Characteristics & Comorbidities Target HbA1c Fasting / Preprandial Glucose Bedtime Glucose

Healthy Older Adults Few coexisting chronic illnesses; intact cognitive and functional independence; substantial life expectancy < 7.0 – 7.5 % <7.0\text{--}7.5\% < 7.0 – 7.5% 80 – 130 mg/dL 80\text{--}130\text{ mg/dL} 80 – 130 mg/dL 80 – 180 mg/dL 80\text{--}180\text{ mg/dL} 80 – 180 mg/dL

Complex / Intermediate Health Multiple coexisting chronic illnesses; mild-to-moderate cognitive impairment; or ≥ 2 \ge 2 ≥ 2 instrumental ADL impairments < 8.0 % <8.0\% < 8.0% 90 – 150 mg/dL 90\text{--}150\text{ mg/dL} 90 – 150 mg/dL 100 – 180 mg/dL 100\text{--}180\text{ mg/dL} 100 – 180 mg/dL

Very Complex / Poor Health Long-term care residents; end-stage chronic disease; moderate-to-severe dementia; or ≥ 2 \ge 2 ≥ 2 basic ADL impairments Avoid reliance on HbA1c; prevent hypoglycemia and symptomatic hyperglycemia 100 – 180 mg/dL 100\text{--}180\text{ mg/dL} 100 – 180 mg/dL 110 – 200 mg/dL 110\text{--}200\text{ mg/dL} 110 – 200 mg/dL

Potential benefit from intensive glycemic treatment depends on prognosis and health, while hypoglycemia can cause immediate falls, confusion, arrhythmias, and injury. Review medications and actual glucose patterns with the prescribing team. Frailty does not imply that all glucose-lowering treatment should stop; retain necessary therapy to prevent symptomatic hyperglycemia.

Primary source check

ESPEN geriatric hydration guideline , checked October 13, 2026.

ADA Older Adults 2026 , checked October 13, 2026.

Ferritin rises with inflammation, and iron deficiency may coexist with inflammatory anemia even when ferritin is not low. Interpret ferritin and transferrin saturation with the clinical setting rather than treating the table as mutually exclusive diagnoses. Early deficiency can have a normal MCV.